The 2nd Annual World Congress Leadership Summit on Personalized Medicine and Medical Policy convenes senior executives from health plans to discuss the advances in medical genetics and the marketing opportunities being created. As new advances in personalized medicine will revolutionize the delivery of health care they also raise a number of questions that health plans need to address on identifying which tests are clinical viable and offer positive outcomes.

The forum will convene leading health plan organizations discussing their perspectives and what opportunities and challenges they see. Topics to be covered include:

• New technological advancements in personalized medicine and what are the most popular and common tests in personalized medicine
• What are effective clinical diagnostic tools to determine the clinical validity of tests
• Discussion on comparative effectiveness and evidence based medicine in respect to personalized medicine research
• New best practices from leading plans on analyzing data and medical policy formation
• Updates on the new CPT codes to be released by the AMA, and how CMS will utilize the new codes
• Legal and ethical implications of personalized medicine from a payer, provider and client perspective
• What is the future of genetic testing? Is the focus expanding to molecular diagnostics as a whole?

By attending this event attendees will walk away with an in depth understanding of the personalized medicine field along with how to formulate policies to govern and provide better quality care for patients.